Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice

Obesity has become a global epidemic, associated with several chronic complications. The intestinal microbiome is a critical regulator of metabolic homeostasis and obesity. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has putative anti-obesity effects. In this study, we used mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Junfeng, Qiu, Hongyan, Xu, Qian, Ma, Yuting, Ye, Tongtong, Kuang, Zengguang, Qu, Na, Kan, Chengxia, Hou, Ningning, Han, Fang, Sun, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830204/
https://www.ncbi.nlm.nih.gov/pubmed/36636340
http://dx.doi.org/10.1016/j.isci.2022.105816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830204/
https://www.ncbi.nlm.nih.gov/pubmed/36636340
http://dx.doi.org/10.1016/j.isci.2022.105816

Ejemplares similares